Home About Us Pipeline News Investors Contacts Careers


Puma Biotechnology, Inc. Corporate Fact Sheet


NEWS

EVENTS

CONTACT


Sept. 3, 2014 - Puma Biotechnology Announces Late-Breaking Oral Presentation on Neratinib in NSCLC with HER2 Mutations at ESMO 2014
Read

Aug. 11, 2014 - Puma Biotechnology Reports Second Quarter 2014 Financial Results
Read

July 22, 2014 - Puma Biotechnology Announces Positive Top Line Results from Phase III PB272 Trial in Adjuvant Breast Cancer (ExteNET Trial)
Read


  • N/A



Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax
info@pumabiotechnology.com


Puma Biotechnology 2013 Annual Report